JERUSALEM--(BUSINESS WIRE)--Hadasit Bio-Holdings Ltd. (TASE:HDST) today announced that ProtAb, its wholly owned portfolio company, has raised $3 million from two of the leading biotechnology investment groups in Israel - Pontifax Fund LP and Clal Biotechnology Industries Ltd. (TASE:CBI), whom will invest $1.5 million each.
